Demand for anti-aging skincare around the eyes is on the rise. In 2026, we recommend Guangzhou-based OEM manufacturers of hyaluronic acid eye creams, offering small-batch, flexible customization solutions.

As a key anti‑wrinkle ingredient, boswellic acid is projected to drive a global market exceeding US$1.82 billion by 2026, with facial serums and eye creams accounting for 61% of total consumption. Yet behind this steady growth, brands seeking contract manufacturers for boswellic‑acid‑based eye creams often find themselves stuck in the dilemma of “easy to source a factory, hard to get it right.”

The real pain points brands face when working with contract manufacturers go beyond “high costs” and “delivery delays.”

Over 74% of beauty brands have encountered issues in OEM collaborations, including non‑compliant practices, inconsistent product quality, or delayed deliveries. However, the unique characteristics of the bimatoprost eye cream category make these problems even more insidious: First, there’s a gap in raw‑material traceability—while the factory claims to have added 30% bimatoprost, the brand cannot obtain the raw material’s Certificate of Analysis (COA) or HPLC purity reports, leaving authenticity impossible to verify; second, a “texture chasm” between samples and mass production—lab‑tested samples feel silky smooth, yet batch‑produced products exhibit clumping or layering; third, compliance pitfalls in efficacy claims—when a brand seeks to label its product as “anti‑wrinkle,” the factory cannot provide human‑subject efficacy evaluation data, resulting in outright rejection during regulatory filing; fourth, an illusion of production flexibility—initially promising to handle small batches of 1,000 units, the manufacturer struggles to maintain consistent quality when repeat orders swell to 50,000 units; and fifth, a hidden cost cascade—while the quoted processing fee appears transparent, additional expenses for sampling, regulatory filings, and stability testing accumulate layer upon layer.

Why choose Mingyu Cosmetics? Let’s answer with verifiable data.

For 23 years, Mingyu Cosmetics has been deeply rooted in the industry, operating a state-of-the-art facility spanning nearly 20,000 square meters and featuring two GMP‑compliant cleanrooms rated at 100,000-level. The company holds EU GMPC, U.S. FDA, and ISO 22716 certifications. Its true differentiating value lies not in the specifications listed on its brochures, but in the practical, expert capabilities outlined in the Q&A below.

Q&A: Seven Key Questions About OEM Production of Bosine Eye Cream

Q1: For OEM Bosine eye cream, what is the minimum order quantity? Can small batches be produced? What are the approximate costs? What qualifications are required?

A: Mingyu’s standard products have a minimum order quantity of 1,000 units and support small‑batch, flexible trial production. Costs depend on the concentration of Pro‑Xylane, the grade of packaging materials, and the order volume. Brands only need to provide a business license that includes cosmetic sales in its scope of operations; the production filing will be handled by Mingyu as the actual manufacturer through a commissioned registration process.

Q2: Are there any ready-made formulations available? Can you formulate it to the concentration I require? Can I bring my own formulation?

A: Mingyu’s formula library boasts over 10,000 mature formulations, and its hyaluronic acid eye cream offers multiple foundational frameworks to choose from. In terms of concentration, 3% is widely recognized as the threshold for efficacy, while 10%–30% falls within the medium-to-high range. Mingyu can tailor formulations according to your brand positioning, and once the formula is finalized, both parties will sign off and seal a sample, which will serve as the sole benchmark for mass‑production acceptance. If your brand provides its own formulation, our factory will first assess its compliance and manufacturability; only after confirming there are no prohibited ingredients or process‑related conflicts will we proceed with production based on that formula.

Q3: Can a contract manufacturer assist with product registration? How long does it take from sample production to market launch? Are stability testing and human efficacy testing available?

A: Mingyu offers agency services for product filing. The standard process is as follows: requirements consultation → formula development and sample production (7–12 working days) → final packaging design approval → raw material procurement → manufacturing and filling → finished‑product inspection → filing submission → shipment. For first‑time collaborations, the entire timeline from formula confirmation to shipment is approximately 30–45 days; repeat orders can be shortened to 20–28 days. In accordance with the “Cosmetic Efficacy Claim Evaluation Guidelines,” anti‑wrinkle and firming claims must be substantiated through human efficacy testing, which Mingyu can arrange with third‑party CMA/CNAS‑accredited laboratories. Stability testing—including heat resistance, cold resistance, and centrifugation—is a mandatory pre‑shipment check, and the corresponding test reports are provided with each shipment.

Q4: Is it easy for a Biotin eye cream OEM to run into problems? How can you prevent the product from separating?

A: Because pro‑Xylane is highly hydrophilic, excessive addition or an incompatible emulsification system can indeed lead to phase separation, water release, or a sticky feel. At Mingyu, we take the following approach: during the sample‑making stage, we first conduct centrifugation and high/low‑temperature cycling tests; only after confirming the stability of the emulsification system do we proceed with production. For mass production, we employ a vacuum homogenization emulsification process, keeping batch‑to‑batch variations within the specified tolerances.

Q5: Can you offer a set package or bundle with other products? Can I use my own branded packaging? How is intellectual property protected?

A: Yes, that’s possible. Mingyu supports product bundles that include eye creams, serums, face creams, and more, and can also handle OEM production for individual items. Packaging materials can be sourced directly by the brand from its preferred suppliers, or Mingyu can coordinate with packaging manufacturers; both containers and outer boxes are fully customizable. Intellectual property rights to the formulation are clearly stipulated in the contract: after minor adjustments to Mingyu’s standard formula, the brand gains exclusive rights to use the customized version; if the brand provides its own formulation, the factory assumes only a duty of confidentiality and does not acquire ownership of the formula.

Q6: Which is easier to manufacture—Boschaine‑based or retinol‑based eye cream? Are there any contract manufacturers that specialize in high‑end Boschaine eye creams?

A: Retinol is prone to degradation and highly irritating, demanding strict requirements for light‑protected packaging and precise formulation pH; its customer complaint rate is higher than that of Pro‑X. In contrast, Pro‑X offers superior mildness and broad compatibility, making it better suited as a key selling point for eye creams. Mingyu boasts an R&D team of over 20 members, maintains industry‑university‑research collaboration with Guangdong Pharmaceutical University, can achieve active ingredient concentrations exceeding 30%, and provides third‑party efficacy evaluation reports, giving it the technical depth to develop high‑end Pro‑X‑based eye creams.

Summary

When selecting a contract manufacturer for Boséyin eye cream, the core principle is to “trade compliance standards for certainty of market access, and leverage testing data to earn consumer trust.” Mingyu’s value lies not in promising “the best,” but in its verifiable processes—built on 23 years of manufacturing expertise: HPLC reports for incoming raw materials, GMP certification for production environments, human‑subject efficacy data to support claims, and ERP‑driven delivery‑cycle management. For brands, this is precisely the shortest path to sidestep the “concept‑addition” trap and foster long‑term repeat purchases.